205 related articles for article (PubMed ID: 30134293)
1. Limitations of the International HIV Dementia Scale in the current era.
Milanini B; Paul R; Bahemana E; Adamu Y; Kiweewa F; Langat R; Owuoth J; Allen E; Polyak C; Ake J; Valcour V;
AIDS; 2018 Nov; 32(17):2477-2483. PubMed ID: 30134293
[TBL] [Abstract][Full Text] [Related]
2. Validity of the International HIV Dementia Scale in South Africa.
Joska JA; Westgarth-Taylor J; Hoare J; Thomas KG; Paul R; Myer L; Stein DJ
AIDS Patient Care STDS; 2011 Feb; 25(2):95-101. PubMed ID: 21214343
[TBL] [Abstract][Full Text] [Related]
3. Screening for HIV-associated neurocognitive disorders in perinatally infected adolescents: youth-International HIV Dementia Scale validation.
Phillips NJ; Thomas KGF; Myer L; Sacktor N; Zar HJ; Stein DJ; Hoare J
AIDS; 2019 Apr; 33(5):815-824. PubMed ID: 30649059
[TBL] [Abstract][Full Text] [Related]
4. The International HIV Dementia Scale: a new rapid screening test for HIV dementia.
Sacktor NC; Wong M; Nakasujja N; Skolasky RL; Selnes OA; Musisi S; Robertson K; McArthur JC; Ronald A; Katabira E
AIDS; 2005 Sep; 19(13):1367-74. PubMed ID: 16103767
[TBL] [Abstract][Full Text] [Related]
5. Cognitive screening in treatment-naïve HIV-infected individuals in Hong Kong - a single center study.
Chan FCC; Chan P; Chan I; Chan A; Tang THC; Lam W; Fong WC; Lee MP; Li P; Chan GHF
BMC Infect Dis; 2019 Feb; 19(1):156. PubMed ID: 30760220
[TBL] [Abstract][Full Text] [Related]
6. A Comparison of Five Brief Screening Tools for HIV-Associated Neurocognitive Disorders in the USA and South Africa.
Joska JA; Witten J; Thomas KG; Robertson C; Casson-Crook M; Roosa H; Creighton J; Lyons J; McArthur J; Sacktor NC
AIDS Behav; 2016 Aug; 20(8):1621-31. PubMed ID: 26860536
[TBL] [Abstract][Full Text] [Related]
7. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
8. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.
Chalermchai T; Valcour V; Sithinamsuwan P; Pinyakorn S; Clifford D; Paul RH; Tipsuk S; Fletcher JL; Degruttola V; Ratto-Kim S; Hutchings N; Shikuma C; Ananworanich J;
J Neurovirol; 2013 Apr; 19(2):137-43. PubMed ID: 23483520
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic Utility of the International HIV Dementia Scale for HIV-Associated Neurocognitive Impairment and Disorder in South Africa.
Goodkin K; Hardy DJ; Singh D; Lopez E
J Neuropsychiatry Clin Neurosci; 2014; 26(4):352-8. PubMed ID: 26037857
[TBL] [Abstract][Full Text] [Related]
10. Improving Detection of HIV-Associated Cognitive Impairment: Comparison of the International HIV Dementia Scale and a Brief Screening Battery.
de Almeida SM; Kamat R; Cherner M; Umlauf A; Ribeiro CE; de Pereira AP; Franklin D; Heaton RK; Ellis RJ
J Acquir Immune Defic Syndr; 2017 Mar; 74(3):332-338. PubMed ID: 27828876
[TBL] [Abstract][Full Text] [Related]
11. Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.
Gouse H; Casson-Crook M; Decloedt EH; Joska JA; Thomas KGF
J Neurovirol; 2017 Oct; 23(5):686-695. PubMed ID: 28748448
[TBL] [Abstract][Full Text] [Related]
12. Validity of the International HIV dementia scale in Brazil.
Rodrigues RA; Oliveira RL; Grinsztejn B; Silva MT
Arq Neuropsiquiatr; 2013 Jun; 71(6):376-9. PubMed ID: 23828527
[TBL] [Abstract][Full Text] [Related]
13. The International HIV Dementia Scale is a useful screening tool for HIV-associated dementia/cognitive impairment in HIV-infected adults in Yaoundé-Cameroon.
Njamnshi AK; Djientcheu Vde P; Fonsah JY; Yepnjio FN; Njamnshi DM; Muna WE
J Acquir Immune Defic Syndr; 2008 Dec; 49(4):393-7. PubMed ID: 19186351
[TBL] [Abstract][Full Text] [Related]
14. [An exploratory study on the diagnostic cutoff value of International HIV-associated Dementia Scale in minority ethnic groups with different educational levels, in Guangxi].
Zhao TT; Feng QM; Liang H; Tang XY; Wei B
Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Nov; 32(11):1101-4. PubMed ID: 22336543
[TBL] [Abstract][Full Text] [Related]
15. Screening for HIV-Associated Neurocognitive Disorder (HAND) in Adults Aged 50 and Over Attending a Government HIV Clinic in Kilimanjaro, Tanzania. Comparison of the International HIV Dementia Scale (IHDS) and IDEA Six Item Dementia Screen.
Kellett-Wright J; Flatt A; Eaton P; Urasa S; Howlett W; Dekker M; Kisoli A; Duijinmaijer A; Thornton J; McCartney J; Yarwood V; Irwin C; Mukaetova-Ladinska E; Akinyemi R; Lwezuala B; Gray WK; Walker RW; Dotchin CL; Makupa P; Paddick SM
AIDS Behav; 2021 Feb; 25(2):542-553. PubMed ID: 32875460
[TBL] [Abstract][Full Text] [Related]
16. Frequency and Predictors of HIV-Related Cognitive Impairment in East Africa: The Africa Cohort Study (AFRICOS).
Milanini B; Allen I; Paul R; Bahemana E; Kiweewa F; Nambuya A; Maswai J; Langat R; Owuoth J; Martin S; Possin K; Esber A; Polyak C; Ake JA; Valcour V;
J Acquir Immune Defic Syndr; 2020 Feb; 83(2):157-164. PubMed ID: 31904698
[TBL] [Abstract][Full Text] [Related]
17. Identifying risk factors for HIV-associated neurocognitive disorders using the international HIV dementia scale.
Cross S; Önen N; Gase A; Overton ET; Ances BM
J Neuroimmune Pharmacol; 2013 Dec; 8(5):1114-22. PubMed ID: 24114509
[TBL] [Abstract][Full Text] [Related]
18. Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment.
Aita SL; Kaewpoowat Q; Yasri S; Rerkasem A; Rerkasem K; Choovuthayakorn J; Ausayakhun S; Robertson K; Roth RM; Robbins NM
J Neurovirol; 2021 Aug; 27(4):568-578. PubMed ID: 34185242
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive impairment among HIV-positive individuals in Botswana: a pilot study.
Lawler K; Mosepele M; Ratcliffe S; Seloilwe E; Steele K; Nthobatsang R; Steenhoff A
J Int AIDS Soc; 2010 Apr; 13():15. PubMed ID: 20406460
[TBL] [Abstract][Full Text] [Related]
20. Normative scores for select neuropsychological battery tests for the detection of HIV-associated neurocognitive disorder amongst Nigerians.
Nweke M; Mshunqane N; Govender N; Akinpelu AO; Ogunniyi A
Niger Postgrad Med J; 2022; 29(3):262-267. PubMed ID: 35900464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
